The latest biotech news

News and Trends 20 Jun 2023

Clearance for anti-tumor bispecific antibody trial

TG ImmunoPharma Co., Ltd. (TGI), which focuses on the development of novel immuno-oncology therapies, says the FDA has granted clearance for the clinical trial of TGI-6, its bispecific antibody. TGI-6 targets unique tumor-associated antigens (TAA) and CD3 molecules simultaneously, enabling potent anti-tumor responses. TGI said the antibody demonstrates exceptional anti-tumor activity, favorable safety profiles, and […]

June 20, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 19 Jun 2023

Allgenesis says dry eye patients’ trial data ‘encouraging’

Allgenesis Biotherapeutics Inc., a clinical-stage specialty pharmaceutical company focused on developing novel ophthalmic drugs, has announced topline data from its phase 1b clinical trial for AG-80308, a first-in-class, formyl peptide receptor (FPR) agonist formulated as an aqueous solution eye drop for the treatment of dry eye disease (DED). AG-80308 was considered safe at all doses […]

June 19, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 19 Jun 2023

Trial shows colorectal cancer drug efficacy

HUTCHMED (China) Limited and Takeda have announced results of their phase III FRESCO‑2 study evaluating fruquintinib in patients with previously treated metastatic colorectal cancer (CRC), which were published in The Lancet. Fruquintinib is a highly selective and potent inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3. FRESCO-2 is a global phase […]

June 19, 2023 - 6 minutesmins - By Jim Cornall

News and Trends 16 Jun 2023

Novartis acquires Chinook Therapeutics for $3.2B

Novartis has entered into an agreement to acquire Chinook Therapeutics, a Seattle, Washington, based clinical stage biopharmaceutical company with two high-value, late-stage medicines in development for rare, severe chronic kidney diseases. The agreed deal, which is subject to customary closing conditions, is in line with Novartis’ strategy to focus on innovative medicines and will expand […]

June 16, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 16 Jun 2023

Key regulator of COVID viral receptor may be new drug target

Entry of the SARS-CoV-2 virus into human tissues depends on the activity of a host gene that regulates production of a key viral receptor, according to a study published in the open access journal PLOS Biology by Madison Strine and Craig Wilen of Yale University, U.S., and colleagues. The finding provides important new information on […]

June 16, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 16 Jun 2023

Flamingo Therapeutics receives €1.7M to advance RNA-targeting oncology portfolio

Flamingo Therapeutics has been awarded a research grant of €1.7 million ($1.9 million) by Flanders Innovation & Entrepreneurship (VLAIO). The award represents the funding at 60% of a €2.9 million ($3.2 million) project. Funding from the grant will be used to advance Flamingo Therapeutics’ RNA-targeting oncology portfolio, including translational research for its lead clinical program, […]

June 16, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 15 Jun 2023

Nordic Bioscience cancer biomarker gets FDA go ahead

Danish biomarker company Nordic Bioscience says its PRO-C3 biomarker assay has received a Letter of Support (LoS) from the U.S. Food and Drug Administration (FDA). The letter acknowledges and supports further study of the PRO-C3 biomarker assay as a prognostic biomarker in tumor fibrosis studies. Nordic Bioscience has a successful track record of developing and […]

June 15, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 15 Jun 2023

Researchers say open-source collaboration is ‘fundamental’

New Seqera Labs data have revealed that 72% of research scientists believe open-source collaboration and workflow management is now “fundamental” to the work they do. The data published by Seqera Labs, a provider of secure data orchestration software, brings together the views of 500 researchers and scientists who use open-source scientific workflow platforms for their […]

June 15, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 15 Jun 2023

Finnish biotech startup Solu raises €1M to combat global antibiotic resistance

Solu, founded in 2022, is a Finnish biotechnology company focusing on combating antibiotic resistance by building the world’s most extensive pathogen DNA library. Solu’s product makes understanding, detecting, and preventing the spread of antibiotic resistance easier and enables real-time monitoring to detect dangerous mutations effectively. The company has recently received seed funding of €1 million […]

June 15, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 15 Jun 2023

IOME Bio claims breakthrough in cancer research

IOME Bio, a French seed stage biotechnology company focused on overcoming tumor resistance to immune checkpoint inhibition, has published its foundational research by founders Arlene Sharpe and Dennis Kasper in Nature. The company said its work reveals unique insights into the critical importance of the RGMb/PD-L2 pathway in immunotherapy resistance and further strengthens the significance […]

June 15, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 15 Jun 2023

New way of identifying proteins supports drug development

All living cells contain proteins with different functions, depending on the type of cell. Researchers at the University of Gothenburg in Sweden have discovered a way to identify proteins even without looking at their structure. They say their method is faster, easier and more reliable than previous methods. Currently, the general view is that each […]

June 15, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 15 Jun 2023

New data on breath biopsy for early detection of lung cancer

Owlstone Medical has announced new data on the development of a screening test for the early detection of lung cancer. The results and research progress were presented in two posters at the EACR 2023 Congress, the annual meeting of the European Association for Cancer Research, held June 12-15 in Torino, Italy. The poster ‘Proof-of-mechanism study […]

June 15, 2023 - 3 minutesmins - By Jim Cornall

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

Clearance for anti-tumor bispecific antibody trial

Allgenesis says dry eye patients’ trial data ‘encouraging’

Trial shows colorectal cancer drug efficacy

Novartis acquires Chinook Therapeutics for $3.2B

Key regulator of COVID viral receptor may be new drug target

Flamingo Therapeutics receives €1.7M to advance RNA-targeting oncology portfolio

Nordic Bioscience cancer biomarker gets FDA go ahead

Researchers say open-source collaboration is ‘fundamental’

Finnish biotech startup Solu raises €1M to combat global antibiotic resistance

IOME Bio claims breakthrough in cancer research

New way of identifying proteins supports drug development

New data on breath biopsy for early detection of lung cancer

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!